79 related articles for article (PubMed ID: 16253165)
1. [The molecular mechanism of PML in inducing apoptosis of bladder cancer cell line].
Li L; He DL; He H; Wang XY; Zhang LL; Luo Y; Nan XY
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1766-9. PubMed ID: 16253165
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of PML induced apoptosis in bladder cancer cell by caspase dependent pathway.
Li L; He D; He H; Wang X; Zhang L; Luo Y; Nan X
Cancer Lett; 2006 May; 236(2):259-68. PubMed ID: 16216409
[TBL] [Abstract][Full Text] [Related]
3. Transfection of promyelocytic leukemia in retrovirus vector inhibits growth of human bladder cancer cells.
Li L; He DL
Acta Pharmacol Sin; 2005 May; 26(5):610-5. PubMed ID: 15842782
[TBL] [Abstract][Full Text] [Related]
4. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the promyelocytic leukemia gene suppresses growth of human bladder cancer cells by inducing G1 cell cycle arrest and apoptosis.
He D; Nan X; Chang KS; Wang Y; Chung LW
Chin Med J (Engl); 2003 Sep; 116(9):1394-8. PubMed ID: 14527374
[TBL] [Abstract][Full Text] [Related]
6. [Increase of BIRC5 gene expression in non-small cell lung cancer and esophageal squamous cell carcinoma does not correlate with expression of genes SMAC/DIABLO and PML encoding its inhibitors].
Vaĭshlia NA; Zinov'eva MV; Sass AV; Kopantsev EP; Vinogradova TV; Sverdlov ED
Mol Biol (Mosk); 2008; 42(4):652-61. PubMed ID: 18856066
[TBL] [Abstract][Full Text] [Related]
7. PML overexpression inhibits proliferation and promotes the osteogenic differentiation of human mesenchymal stem cells.
Sun J; Fu S; Zhong W; Huang H
Oncol Rep; 2013 Dec; 30(6):2785-94. PubMed ID: 24101171
[TBL] [Abstract][Full Text] [Related]
8. Characterization of endogenous human promyelocytic leukemia isoforms.
Condemine W; Takahashi Y; Zhu J; Puvion-Dutilleul F; Guegan S; Janin A; de Thé H
Cancer Res; 2006 Jun; 66(12):6192-8. PubMed ID: 16778193
[TBL] [Abstract][Full Text] [Related]
9. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis.
Le XF; Vallian S; Mu ZM; Hung MC; Chang KS
Oncogene; 1998 Apr; 16(14):1839-49. PubMed ID: 9583681
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
Bøe SO; Haave M; Jul-Larsen A; Grudic A; Bjerkvig R; Lønning PE
J Cell Sci; 2006 Aug; 119(Pt 16):3284-95. PubMed ID: 16868026
[TBL] [Abstract][Full Text] [Related]
11. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
12. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.
Day PM; Baker CC; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14252-7. PubMed ID: 15383670
[TBL] [Abstract][Full Text] [Related]
13. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
14. [Expression of promyelocytic leukaemia protein in lung carcinomas and clinical significance thereof].
Zhao ZL; Huang QY; Xu S; Zhang L; Zhao HR
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3362-6. PubMed ID: 17313836
[TBL] [Abstract][Full Text] [Related]
15. E1A-mediated suppression of EGFR expression and induction of apoptosis in head and neck squamous carcinoma cell lines.
Flinterman M; Gäken J; Farzaneh F; Tavassoli M
Oncogene; 2003 Apr; 22(13):1965-77. PubMed ID: 12673202
[TBL] [Abstract][Full Text] [Related]
16. Nuclear matrix associated protein PML: an arsenic trioxide apoptosis therapeutic target protein in HepG2 cells.
Yu D; Wang Z; Zhu L; Chew EC
Chin Med J (Engl); 2003 Jan; 116(1):93-8. PubMed ID: 12667397
[TBL] [Abstract][Full Text] [Related]
17. Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells.
Vannucchi S; Percario ZA; Chiantore MV; Matarrese P; Chelbi-Alix MK; Fagioli M; Pelicci PG; Malorni W; Fiorucci G; Romeo G; Affabris E
Oncogene; 2000 Oct; 19(44):5041-53. PubMed ID: 11042692
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia protein 4 induces apoptosis by inhibition of survivin expression.
Xu ZX; Zhao RX; Ding T; Tran TT; Zhang W; Pandolfi PP; Chang KS
J Biol Chem; 2004 Jan; 279(3):1838-44. PubMed ID: 14597622
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
Komura N; Asakawa M; Umezawa K; Segawa K
Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
[TBL] [Abstract][Full Text] [Related]
20. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer.
Zhang H; Melamed J; Wei P; Cox K; Frankel W; Bahnson RR; Robinson N; Pyka R; Liu Y; Zheng P
Cancer Immun; 2003 Feb; 3():2. PubMed ID: 12747744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
